I was taking a look around some of the data for antidepressants and was wondering why there are sometimes such drastic decreases in spending. Spending for Escitalopram dropped over 80% in a single month[1]. There are a few others that had sharp drops in spending. Just curious, do you know why?<p>In any case, it would be really interesting to see how legislation, lobbying, and current events (relative) may have affected this data.<p>[1]: <a href="https:&#x2F;&#x2F;openprescribing.net&#x2F;chemical&#x2F;0403030X0" rel="nofollow">https:&#x2F;&#x2F;openprescribing.net&#x2F;chemical&#x2F;0403030X0</a>